Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Deferoxamine

2

II.a Pulmonary edema, noncardiogenic (NCPE)

1
Last update : 08/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine.
American journal of hematology 1998 Aug;58;340-1 1998 Aug
Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions.
American journal of diseases of children (1960) 1990 May;144;565-9 1990 May

Powered by

  • ^
  • Contact
  • Cookies
  • About